Is your company currently looking to establish or increase vaccine manufacturing capacity? The race to meet demand for COVD-19 vaccines (and therapies) has dramatically reshaped the planning and execution of pharmaceutical manufacturing capital projects. And when it comes to vaccines, a proper understading of the specific synthesis and formulation processes involved – and the current challenges therein – is essential for success. Without it, capital projects cannot be executed on time or budget in this highly challenging and dynamic environment.
In this multi-part webinar series, we will methodically review the synthesis and formulation processes for the various vaccine types and outline the implications for any company currently looking to establish or increase manufacturing capacity. COVID-19 vaccines will be covered in depth during the series.
Join our subject matter expert Christian Lavarreda on this first installment of " Vaccine Synthesis and Formulation Processes" on Thursday, July 8, 2021. This event will last approximately 30 minutes and include an interactive Q&A session.